Annual Accounts Payable
$5.45 M
+$2.11 M+63.22%
31 December 2023
Summary:
Keros Therapeutics annual accounts payable is currently $5.45 million, with the most recent change of +$2.11 million (+63.22%) on 31 December 2023. During the last 3 years, it has risen by +$3.30 million (+153.61%). KROS annual accounts payable is now at all-time high.KROS Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$4.98 M
-$1.55 M-23.78%
30 September 2024
Summary:
Keros Therapeutics quarterly accounts payable is currently $4.98 million, with the most recent change of -$1.55 million (-23.78%) on 30 September 2024. Over the past year, it has increased by +$1.11 million (+28.81%). KROS quarterly accounts payable is now -34.97% below its all-time high of $7.66 million, reached on 30 June 2022.KROS Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KROS Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +63.2% | +28.8% |
| 3 y3 years | +153.6% | +77.2% |
| 5 y5 years | +987.8% | - |
KROS Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +153.6% | -35.0% | +87.6% |
| 5 y | 5 years | at high | +987.8% | -35.0% | +263.1% |
| alltime | all time | at high | +987.8% | -35.0% | +263.1% |
Keros Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $4.98 M(-23.8%) |
| June 2024 | - | $6.54 M(+31.1%) |
| Mar 2024 | - | $4.99 M(-8.5%) |
| Dec 2023 | $5.45 M(+63.2%) | $5.45 M(+40.9%) |
| Sept 2023 | - | $3.87 M(-6.7%) |
| June 2023 | - | $4.15 M(-11.4%) |
| Mar 2023 | - | $4.68 M(+40.2%) |
| Dec 2022 | $3.34 M | $3.34 M(+25.8%) |
| Sept 2022 | - | $2.65 M(-65.3%) |
| June 2022 | - | $7.66 M(+150.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $3.06 M(-15.9%) |
| Dec 2021 | $3.65 M(+69.6%) | $3.65 M(+29.7%) |
| Sept 2021 | - | $2.81 M(+104.9%) |
| June 2021 | - | $1.37 M(-54.4%) |
| Mar 2021 | - | $3.01 M(+40.0%) |
| Dec 2020 | $2.15 M(+2.9%) | $2.15 M(+25.2%) |
| Sept 2020 | - | $1.72 M(-64.6%) |
| June 2020 | - | $4.85 M(+100.0%) |
| Mar 2020 | - | $2.43 M(+16.2%) |
| Dec 2019 | $2.09 M(+316.8%) | $2.09 M |
| Dec 2018 | $501.00 K | - |
FAQ
- What is Keros Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Keros Therapeutics?
- What is Keros Therapeutics annual accounts payable year-on-year change?
- What is Keros Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Keros Therapeutics?
- What is Keros Therapeutics quarterly accounts payable year-on-year change?
What is Keros Therapeutics annual accounts payable?
The current annual accounts payable of KROS is $5.45 M
What is the all time high annual accounts payable for Keros Therapeutics?
Keros Therapeutics all-time high annual accounts payable is $5.45 M
What is Keros Therapeutics annual accounts payable year-on-year change?
Over the past year, KROS annual accounts payable has changed by +$2.11 M (+63.22%)
What is Keros Therapeutics quarterly accounts payable?
The current quarterly accounts payable of KROS is $4.98 M
What is the all time high quarterly accounts payable for Keros Therapeutics?
Keros Therapeutics all-time high quarterly accounts payable is $7.66 M
What is Keros Therapeutics quarterly accounts payable year-on-year change?
Over the past year, KROS quarterly accounts payable has changed by +$1.11 M (+28.81%)